Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-15

Clinical Trial Update: Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease [Phase 4]

View source ↗

Summary

An update on a Phase 4 trial evaluating the combination of radiotherapy and intravenous steroids for early progressive Graves' ophthalmopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: University of British Columbia | Conditions: Graves Ophthalmopathy | Phase 4 | Status: UNKNOWN